Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
15-probe cocktail----1件: 254 💬
2A novel synthetic, orally-administered, NON-peptide small molecule, which acts AS----1件: 254 💬
3Afamelanotide1件: Afamelanotide2件: Afamelanotide ,
Afamelanotide acetate 💬 		1件: MC1R 💬 3件: Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬2件: 159, 254 💬
4Afamelanotide 16 MG1件: Afamelanotide2件: Afamelanotide ,
Afamelanotide acetate 💬 		1件: MC1R 💬 3件: Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 254 💬
5Afamelanotide 16MG implant1件: Afamelanotide2件: Afamelanotide ,
Afamelanotide acetate 💬 		1件: MC1R 💬 3件: Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 254 💬
6Afamelanotide implant1件: Afamelanotide2件: Afamelanotide ,
Afamelanotide acetate 💬 		1件: MC1R 💬 3件: Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬1件: 254 💬
7ALN-60519----1件: 254 💬
8ALN-AS1----1件: 254 💬
9Chlorpromazine hydrochloride1件: Chlorpromazine2件: Chlorpromazine ,
Chlorpromazine hydrochloride 💬 		13件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5,
DRD2,
HRH1,
HTR2,
HTR2,
HTR2 💬 		24件: Alcoholism, Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Hormone signaling, Inflammatory mediator regulation of TRP channels, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Regulation of actin cytoskeleton, Salivary secretion, Serotonergic synapse, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 254 💬
10Cimetidine1件: Cimetidine2件: Cimetidine ,
Cimetidine hydrochloride 💬 		1件: HRH2 💬 4件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 254 💬
11Colestipol1件: Colestipol2件: Colestipol hydrochloride ,
Colestipol 💬 		--1件: 254 💬
12Colestyramine1件: Cholestyramine1件: Cholestyramine resin 💬 --1件: 254 💬
13CUV1647----1件: 254 💬
14Cysteine hydrochloride1件: Cysteine2件: L-Cysteine ,
Cysteine hydrochloride 💬 		--1件: 254 💬
15Deferasirox1件: Deferasirox1件: Deferasirox 💬 --4件: 54, 254, 284, 286 💬
16Dersimelagon1件: Dersimelagon1件: Dersimelagon 💬 1件: MC1R 💬 3件: Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬2件: 51, 254 💬
17DISC-1459----1件: 254 💬
18Dosage OF delta-aminolevulinic acid and porphobilinogen----1件: 254 💬
19Exjade1件: Deferasirox1件: Deferasirox 💬 --3件: 254, 284, 286 💬
20Givosiran1件: Givosiran2件: Givosiran ,
Givosiran sodium 💬 		1件: E2.3.1.37 💬 2件: Glycine, serine and threonine metabolism, Porphyrin metabolism 💬1件: 254 💬
21Glucose1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--9件: 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
22Heme arginate1件: Heme arginate---1件: 254 💬
23Hemin1件: Hemin1件: Hemin 💬 2件: E2.3.1.37,
E2.3.1.37 💬 		2件: Glycine, serine and threonine metabolism, Porphyrin metabolism 💬1件: 254 💬
24Hemin FOR injection1件: Hemin1件: Hemin 💬 2件: E2.3.1.37,
E2.3.1.37 💬 		2件: Glycine, serine and threonine metabolism, Porphyrin metabolism 💬1件: 254 💬
25Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--26件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
26Isoniazid1件: Isoniazid1件: Isoniazid 💬 --1件: 254 💬
27Luteinizing hormone-releasing factor1件: Luteinizing hormone---1件: 254 💬
28MT-7117----2件: 51, 254 💬
29MT-7117 high dose----1件: 254 💬
30MT-7117 LOW dose----1件: 254 💬
31NLE4-D-PHE7-alpha-MSH----1件: 254 💬
32Oral iron----2件: 97, 254 💬
33Panhematin----1件: 254 💬
34Phlebotomy----3件: 89, 158, 254 💬
35Porphozym1件: Porphobilinogen deaminase, human recombinant---1件: 254 💬
36PORT-77----1件: 254 💬
37Questran1件: Cholestyramine1件: Cholestyramine resin 💬 --4件: 93, 254, 297, 338 💬
38RAAV2/5-pbgd vector dosage 1----1件: 254 💬
39RAAV2/5-pbgd vector dosage 2----1件: 254 💬
40RAAV2/5-pbgd vector dosage 3----1件: 254 💬
41RAAV2/5-pbgd vector dosage 4----1件: 254 💬
42Recombinant human porphobilinogen deaminase1件: Porphobilinogen deaminase, human recombinant---1件: 254 💬
43Scenesse1件: Afamelanotide2件: Afamelanotide ,
Afamelanotide acetate 💬 		1件: MC1R 💬 3件: Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬3件: 159, 161, 254 💬
44TIN mesoporphyrin1件: Stannsoporfin1件: Stannsoporfin 💬 2件: HMOX1,
HMOX2 💬 		9件: Chemical carcinogenesis - reactive oxygen species, Ferroptosis, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatocellular carcinoma, MicroRNAs in cancer, Mineral absorption, Pathways in cancer, Porphyrin metabolism 💬1件: 254 💬